Aatmaj Healthcare Ltd (AATMAJ) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Aatmaj Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
H1 FY26-27 Investor Dossier & Comprehensive Management FAQs
Others (Uncategorized) · 01 Nov 2026, 3:30 pm
Aatmaj Healthcare H1 FY27 Performance Update and Growth Strategy Aatmaj Healthcare reported H1 FY27 revenue from operations of ₹16.96 Cr, up 56.89% YoY, while EBITDA grew 15.25% YoY to ₹2.04 Cr. PAT stood at ₹0.37 Cr, down 27.45% YoY due to higher finance costs (₹98.74 lakh) and incremental depreciation from recent expansions. Management guided for ~80% full-year FY27 revenue growth (~₹40.55 Cr). Receivables days improved significantly to ~251 days from ~397 days in FY26, with cash and equivalents at ₹12.78 Cr against borrowings of ₹23.16 Cr. Growth is driven by capacity ramp-ups and high-margin IVF expansion.
Aatmaj Healthcare Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Aatmaj_Healthcare_H1_FY2627_Press_Release".
Press Release · 30 Oct 2026, 3:59 am
Aatmaj Healthcare Reports 57% Revenue Growth and Improved Working Capital in H1 FY27 Aatmaj Healthcare announced its H1'FY27 results, reporting a 57% YoY increase in revenue from operations to Rs. 16.96 crore, up from Rs. 10.81 crore in H1'FY26. Total revenue reached Rs. 17.39 crore against Rs. 11.25 crore in the prior-year period. EBITDA grew 15% YoY to Rs. 2.04 crore compared to Rs. 1.77 crore. Working capital efficiency improved substantially, with receivables declining to Rs. 23.30 crore as of 30th Sep'26, reducing receivable days from 369 to 251. The company targets approximately 80% revenue growth for full-year FY27.
Aatmaj Healthcare Limited has informed the Exchange regarding 'Investor Presentation on Unaudited Standalone Financial Results 30.9.26'.
Investor Presentation · 30 Oct 2026, 12:03 am
Aatmaj Healthcare Reports H1 FY27 Results and Expansion Strategy Aatmaj Healthcare reported revenue from operations of ₹1,695.98 lakh for the half-year ended 30th Sep'26, up 56.9% YoY from ₹1,081.04 lakh in H1 FY26. Net profit declined to ₹36.95 lakh versus ₹51.07 lakh YoY, impacted by expansion expenses, higher finance costs, and ramp-up costs for new CTVS and IVF units. Key operational metrics include 250+ beds capacity, ~65%-70% occupancy, and ARPOB of ₹24,500+. Management targets ~40% revenue growth in H2 FY27 and ~80% YoY increase in annual PAT, supported by Anand Hospital consolidation.
Submission of Standalone Un-audited Financial Results 30.9.26
Others (Uncategorized) · 29 Oct 2026, 11:54 pm
Aatmaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 29 Oct 2026, 11:48 pm
Aatmaj Healthcare Reports H1 FY27 Results with Revenue Growth but Lower Net Profit For the half-year ended 30th Sep'26, Aatmaj Healthcare reported standalone revenue from operations of ₹1,695.98 lakhs, up 56.88% YoY from ₹1,081.04 lakhs in the corresponding period ended 30th Sep'25. Net profit for the period dropped 27.65% YoY to ₹36.95 lakhs compared to ₹51.07 lakhs in H1 FY26, impacted by higher cost of materials consumed, employee benefits, and finance expenses. Basic and diluted EPS stood at ₹0.16 against ₹0.23 YoY, while total revenue reached ₹1,738.52 lakhs.
Aatmaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 29 Oct 2026, 11:26 pm
Aatmaj Healthcare Reports H1 FY27 Results with Revenue Growth and Margin Contraction Aatmaj Healthcare reported standalone revenue from operations of ₹1,695.98 lakh for the half-year ended 30th Sep'26, up 56.88% YoY from ₹1,081.04 lakh in the corresponding period ended 30th Sep'25. However, net profit declined 27.65% YoY to ₹36.95 lakh compared to ₹51.07 lakh, pressured by higher material costs, employee benefits, and finance charges of ₹98.74 lakh. Basic EPS stood at ₹0.16 against ₹0.23 YoY. Total assets reached ₹7,956.31 lakh, while net operating cash flow for the half-year stood at ₹121.37 lakh.
AATMAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
Aatmaj Healthcare Schedules Board Meeting on 29th Oct'26 for Half-Yearly Results Aatmaj Healthcare Limited has informed the exchange that its Board of Directors is scheduled to meet on 29th Oct'26. The board will inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
AATMAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
Aatmaj Healthcare Schedules Board Meeting on 29th Oct'26 for Half-Yearly Results Aatmaj Healthcare Limited has scheduled its Board of Directors meeting on 29th Oct'26. The board will convene primarily to consider, review, and approve the company's standalone unaudited financial results for the half-year ended Sep'26, alongside other routine corporate business matters.
Aatmaj Healthcare Limited has informed the Exchange about Board Meeting for consideration of results 30 09 2026
Intimation · 29 Oct 2026, 5:30 am
Aatmaj Healthcare Schedules Board Meeting to Consider Half-Year Financial Results Aatmaj Healthcare Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the un-audited standalone financial results for the half year ended 30th Sep'26, alongside the statutory auditor's limited review report. Additionally, the trading window for dealing in company securities remains closed for designated insiders and will reopen 48 hours after the formal declaration of the half-year results.
Compliance Certificate on SDD Quarter ended 30.9.2026
Others (Uncategorized) · 13 Oct 2026, 9:37 pm
Aatmaj Healthcare Submits SEBI PIT Compliance Certificate for Q2 FY27 Aatmaj Healthcare Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended 30th Sep'26, pursuant to Regulations 3(5) and 3(6) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Certified by practicing company secretary K Parikh & Associates on 13th Oct'26, the company confirmed an internally maintained, non-tamperable SDD system with audit trail capabilities for eight years. The report noted zero required UPSI events during the period from 1st Jul'26 to 30th Sep'26 and reported zero instances of non-compliance.
Investors Grievances for the quarter ended 30th September, 2026
Others (Uncategorized) · 13 Oct 2026, 9:04 pm
Aatmaj Healthcare Reports Nil Investor Grievances for Quarter Ended Sep'26 Aatmaj Healthcare Limited reported zero investor complaints for the quarter ended 30th Sep'26, in compliance with Regulation 13(3) of SEBI Listing Regulations. The company recorded zero pending complaints at the start of the quarter on 1st Jul'26, received no new complaints during the three-month period, and concluded the quarter on 30th Sep'26 with nil pending investor grievances.
Outcome of 12th AGM
Others (Uncategorized) · 29 Sept 2026, 2:09 pm
Aatmaj Healthcare Limited has informed the Exchange regarding 'Notice of 12th AGM to be held on 17th September, 2026 at 4.30 p.m. through Video Conferencing'.
Annual General Meeting · 20 Aug 2026, 11:18 pm
Aatmaj Healthcare Limited has informed the Exchange regarding 'Investor update & Performance overview for the 1st Quarter F.y. 2026-27 '.
Others (Uncategorized) · 03 Aug 2026, 11:26 pm
Aatmaj Healthcare Q1FY27 Results: Strong Revenue and Profit Growth Aatmaj Healthcare reported robust Q1 FY26-27 performance with revenue growing 60% YoY to INR 8.13 crore. Profit before tax & depreciation surged 170% YoY to INR 1.52 crore, with margins expanding from 11.08% to 18.76%. The company expanded its network by acquiring Anand Hospital in Vadodara, which is expected to generate INR 9-9.5 crore in revenue and INR 2.5-3 crore in profit in FY26-27. Strategic initiatives also include a new CTVS department, an IVF center, and empanelment under the PM-JAY scheme.
Submission of integrated filing governance for quarter ended June 30 2026.
Others (Uncategorized) · 20 Jul 2026, 9:56 pm
Aatmaj Healthcare Submits Q1 FY27 Integrated Filing Governance Report Aatmaj Healthcare submitted its Integrated Filing Governance report for the quarter ended 30-Jun'26, confirming compliance with SEBI regulations. The company held two board meetings during the quarter on 24-Mar'26 and 14-May'26, with a maximum gap of 50 days. It affirmed that its Board of Directors and key committees (Audit, Nomination & Remuneration, Stakeholders Relationship) are properly constituted. No investor complaints were pending, received, or disposed of during the quarter. The company also reported no cybersecurity incidents.
Compliance Certificate on SDD for quarter ended 30 6 2026.
Others (Uncategorized) · 14 Jul 2026, 7:05 pm
Aatmaj Healthcare Submits Q1FY27 Insider Trading Compliance Certificate Aatmaj Healthcare Limited (AATMAJ) filed its compliance certificate for the quarter ended 30 Jun'26, as required by SEBI's Prohibition of Insider Trading Regulations, 2015. The certificate confirms the company maintains a Structured Digital Database (SDD) for Unpublished Price Sensitive Information (UPSI). A practicing Company Secretary verified the system is in place, is non-tamperable with an audit trail, and captures required data. The report noted that there were nil events requiring capture during the quarter and no non-compliances observed.
Aatmaj Healthcare Limited has informed the Exchange regarding 'Status of Investor Grievances as of 30 6 2026'.
Others (Uncategorized) · 14 Jul 2026, 6:51 pm
Aatmaj Healthcare Reports No Investor Grievances for Q1 FY27 Aatmaj Healthcare Limited filed its investor grievance report for the quarter ended Jun 30, 2026. The company reported zero complaints pending at the beginning of the quarter. No new complaints were received or resolved during the period, resulting in zero complaints outstanding at the quarter's end. The filing was made in compliance with SEBI's Listing Obligations and Disclosure Requirements regulations.
Investor Complaints Status as on 30 6 2026
Others (Uncategorized) · 14 Jul 2026, 6:46 pm
Aatmaj Healthcare Reports Zero Investor Grievances for Q1FY27 Aatmaj Healthcare reported zero investor complaints for the quarter ended 30-Jun'26. The company had no pending complaints at the beginning of the quarter, received no new complaints, and consequently, resolved none. As of 30-Jun'26, the number of pending investor grievances remained at zero. This filing was submitted to the NSE in compliance with SEBI's Listing Obligations and Disclosure Requirements regulations.
The Exchange had sought clarification from Aatmaj Healthcare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Others (Uncategorized) · 25 Jun 2026, 10:12 pm